Dr. West is a genius! Device ok'd within months, product roll out/partnerships by mid year. 800lb Gorilla gonna come out on top by 2014.
Great buying opportunity!
ACTC is ahead but Biotime has learned from their process, so when we start trials soon with TEVA we will hit the ground running. A major advantage we have over ACTC is that our product is Xeno free...
Cell Cure’s OpRegen® is “xeno-free”, meaning that no animal products were used in the culture of the human embryonic stem cell-derived RPE cells. The use animal products to culture cells often results in the designation of the therapy as a “xenotransplantation” product, even though the cells themselves are of human origin. Xenotransplantation may raise purity issues, increasing the costs of product development along with other risks and uncertainties. The production of animal product-free OpRegen® will therefore eliminate concerns of xenotransplantation and may provide cost savings in development and production should the product successfully complete clinical trials and be approved for human use.
Would be nice if Rafii gave an update on BTX pre-clinical studies!
Hystem turns out to be a good 'Picks & Shovels' purchase! Dr. West does it again!
I don't know about next week, but you should be holding mid may when we showcase at the Gene Therapy Confeerence in Philadelphia.
Many reasons why Biotime will be the next Amgen. Personally i think the cartilage regen will be a major winner. I remember Dr. West said the Oakland Raiders practice not far from the biotime headquarters and showed interest.
Very cool stuff......"See you next week"!